Overview

The Treatment Principles (Australian Participants in British Nuclear Tests) 2006 (Minor & Technical Variations (2)) Instrument 2011 was enacted to amend the Treatment Principles (Australian Participants in British Nuclear Tests) 2006, addressing minor and technical variations. The Act, Australian Participants in British Nuclear Tests (Treatment) Act 2006, was introduced to provide treatment for Australian participants in British nuclear tests who developed malignant neoplasia. The instrument was made under subsection 16(7) of the Act by the Australian Government, with the policy objective of rectifying drafting errors and updating references to incorporated documents to ensure the most current versions are applied. The benevolent nature of the instrument ensures that its retrospective commencement does not disadvantage any person or impose liabilities contrary to the Legislative Instruments Act 2003.

Scope and Application

The Treatment Principles (Australian Participants in British Nuclear Tests) 2006 (Minor & Technical Variations (2)) Instrument 2011, as an amendment to the Treatment Principles, applies to Australian participants in British nuclear tests, who are referred to as entitled persons under the Australian Participants in British Nuclear Tests (Treatment) Act 2006. This Act governs the circumstances under which the Repatriation Commission may accept financial liability for treatment provided to these entitled persons for malignant neoplasia. The instrument rectifies minor drafting errors and updates references to incorporated documents to ensure the Principles accurately reflect the current state of relevant external documents as they existed on 1 November 2011. The instrument's benevolent nature ensures that it may commence before registration without contravening subsection 12(2) of the Legislative Instruments Act 2003. The instrument's application extends nationally, given its origin under the Commonwealth Act, and it incorporates by reference a range of fee schedules and guidelines from the Department of Veterans' Affairs, making them part of the Principles. This inclusion facilitates consistent and updated fee structures and operational guidelines for the treatment of entitled persons.

Key Provisions

The Treatment Principles (Australian Participants in British Nuclear Tests) 2006 (Minor & Technical Variations (2)) Instrument 2011, made under subsection 16(7) of the Australian Participants in British Nuclear Tests (Treatment) Act 2006, primarily serves to correct minor drafting errors and update references to incorporated documents within the Treatment Principles (the Principles). These updates ensure that the latest versions of external documents, such as fee schedules and service notes for various healthcare providers, are incorporated into the Principles. This is crucial for maintaining the accuracy and relevance of the Principles in guiding the Repatriation Commission’s (the Commission) acceptance of financial liability for treatment provided to entitled persons for malignant neoplasia. Under this Act, the Commission is responsible for ensuring that the treatment of entitled persons, who are Australian participants in British nuclear tests, aligns with the updated and corrected Principles. This involves adhering to the revised guidelines and references, which encompass a broad range of medical services and fees as specified by the Department of Veterans' Affairs. The obligation falls on the Commission to apply these updated Principles consistently in their decision-making processes regarding financial liability for treatment of entitled persons. Failure to comply with the updated Principles or the Act may result in legal consequences. While specific offences, penalties, or civil/criminal consequences are not detailed in the Explanatory Statement, it is implied that non-compliance could lead to legal challenges or disputes regarding the financial liability for treatment. The legislative intent is benevolent, aiming to protect and support entitled persons, and thus, the instrument is designed to avoid any disadvantages or liabilities imposed on individuals due to its retrospective application, as per subsection 12(2) of the Legislative Instruments Act 2003. The instrument’s benevolent nature ensures that it does not disadvantage individuals, even if it takes effect before registration, thereby maintaining the integrity and fairness of the treatment provisions for entitled persons. It is also noteworthy that no consultation was deemed necessary as the changes are minor and technical, reflecting a streamlined approach to legislative amendments aimed at ensuring the continued effectiveness and accuracy of the Principles.